Dey pays $2.9M to settle price-reporting litigation
Pharma Compliance Alert, April 25, 2007
California-based Dey, Inc., has paid $2.9 million to Massachusetts to settle alleged inflated wholesale acquisition costs (WAC), according to Massachusetts Attorney General Martha Coakley's office.
The settlement resolves price reporting litigation pending the Federal District Court in Boston. The Commonwealth alleged that Dey reported inflated WAC to national price reporting services, causing the Massachusetts Medicaid program to overpay for Dey drugs.
In addition to the $2.9 million Dey has agreed to pay, the company will also pay Massachusetts a 5% rebate on future purchases for five years. Although it agreed to the settlement, Dey denied any wrongdoing and said that its price reporting was consistent with legal standards.
Go to the Massachusetts attorney general's Web site to read more.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched